CI
ARNA

Cowen Inc’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Cowen Inc’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-1,000
Closed -$59K – 250
2013
Q4 		$59K Hold
1,000
– – 0.01% 211
2013
Q3 		$53K Sell
1,000
-500
-33% -$33.6K 0.01% 205
2013
Q2 		$116K Buy
+1,500
New +$122K 0.01% 229

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Cowen Inc's ARNA Position: Q1 2014 in Review

Cowen Inc sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2014, closing a stake of 1,000 shares — an estimated $59K sold.

Cowen Inc first reported a position in ARNA in Q2 2013 and held it in 3 quarters. The position peaked at $116K in Q2 2013. 131 funds tracked by Wall St. Rank hold ARNA as of Q1 2014.

  • Cowen Inc reported no remaining Arena Pharmaceuticals Inc position as of Q1 2014 after selling out during the quarter.
  • Cowen Inc sold 1,000 Arena Pharmaceuticals Inc shares in Q1 2014, an estimated $59K.
  • Cowen Inc first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and held it in 3 quarters.
  • Cowen Inc's Arena Pharmaceuticals Inc position peaked at $116K in Q2 2013.
  • 131 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2014.

Based on Cowen Inc's 13F filing for Q1 2014, filed 16 May 2014.